Accelerating type-specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (COSP) is a reliable high-throughput tool for case review (Q38137231)

From Wikidata

Jump to navigation Jump to search

scientific article published on 02 September 2013

Language	Label	Description	Also known as
English	Accelerating type-specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (COSP) is a reliable high-throughput tool for case review	scientific article published on 02 September 2013

Statements

scholarly article

1 reference

Europe PubMed Central

29 August 2017

Accelerating type-specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (COSP) is a reliable high-throughput tool for case review (English)

1 reference

Europe PubMed Central

29 August 2017

ovarian carcinoma

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24033430%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Michael S Anglesio

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24033430%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

5

object named as

Felix Hilpert

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24033430%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Stefan Kommoss

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24033430%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Cyril Blake Gilks

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24033430%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Friedrich Kommoss

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24033430%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Christine Chow

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24033430%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Andreas du Bois

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24033430%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

David G Huntsman

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24033430%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Steve E Kalloger

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24033430%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Jacobus Pfisterer

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24033430%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

2 September 2013

1 reference

Europe PubMed Central

29 August 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24033430%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

63

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24033430%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24033430%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

704-712

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24033430%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG study

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

Clinicopathologic analysis of early-stage sporadic ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

Pathology slide review in gynecologic oncology

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

Calculator for ovarian carcinoma subtype prediction

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

A phase 3 trial of bevacizumab in ovarian cancer

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

ARID1A mutations in endometriosis-associated ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

Architectural patterns of ovarian/pelvic high-grade serous carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

Ovarian low-grade serous carcinoma: a comprehensive update

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

Mixed clear cell and endometrioid carcinoma arising in parietal endometriosis

1 reference

https://api.crossref.org/works/10.1111%2FHIS.12219

21 January 2018

Identifiers

10.1111/HIS.12219

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24033430%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24033430%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38137231&oldid=2046290191"